Cyclin A2 Regulates Symmetrical Mitotic Spindle Formation and Centrosome Amplification in Human Colon Cancer Cells
Overview
Authors
Affiliations
Colon cancer is one of the most fatal cancers in the United States, and is characterized by the presence of chromosomal instability (CIN), causes of which are largely unclear. Emerging evidence indicates that abnormal spindle geometry and supernumerary centrosomes lead to CIN in cells. However, if and how spindle geometry defects and centrosomes amplification occur in colon cancer remains unknown. Here we show that decrease in the cell cycle regulatory protein, cyclin A2, induces spindle geometry defects in colon cancer cells. In mechanistic studies, we found that cyclin A2 is located at the centrosomes, and its depletion reduces phosphorylation of EG5, which is important for centrosome localization and movement of duplicated centrosomes to opposite poles. We also found that cyclin A2 silencing leads to centrosome amplification in the cells. Collectively, these findings demonstrate previously unrecognized role for cyclin A2 in preventing centrosomal defects in colon cancer cells and provide insights into mechanisms that may potentially cause CIN in these tumors.
Mitotic Functions and Characters of KIF11 in Cancers.
Gao W, Lu J, Yang Z, Li E, Cao Y, Xie L Biomolecules. 2024; 14(4).
PMID: 38672404 PMC: 11047945. DOI: 10.3390/biom14040386.
Molecular subtyping in colorectal cancer: A bridge to personalized therapy (Review).
Wang C, Zhang H, Liu Y, Wang Y, Hu H, Wang G Oncol Lett. 2023; 25(6):230.
PMID: 37153060 PMC: 10157608. DOI: 10.3892/ol.2023.13816.
Li Z, Zhang Y, Zhou Y, Wang F, Yin C, Ding L Sci Rep. 2021; 11(1):23681.
PMID: 34880385 PMC: 8654884. DOI: 10.1038/s41598-021-03166-2.
Cyclin A2 localises in the cytoplasm at the S/G2 transition to activate PLK1.
Silva Cascales H, Burdova K, Middleton A, Kuzin V, Mullers E, Stoy H Life Sci Alliance. 2021; 4(3).
PMID: 33402344 PMC: 7812317. DOI: 10.26508/lsa.202000980.
Cyclin A2 maintains colon homeostasis and is a prognostic factor in colorectal cancer.
Guo Y, Gabola M, Lattanzio R, Paul C, Pinet V, Tang R J Clin Invest. 2020; 131(4).
PMID: 33332285 PMC: 7880422. DOI: 10.1172/JCI131517.